Form 4: Anterix Director William Heard Receives Stock Grant
Insider Transaction Report
Anterix Inc. Director and 10% owner William Heard was granted 7,767 shares of common stock as compensation for his board service.
Summary
- William Heard, a Director and 10% owner of Anterix Inc. (ATEX), acquired 7,767 shares of Common Stock.
- The shares were granted as restricted stock compensation for his service as a non-employee director.
- The grant price for the acquired shares was $0.
- The restricted stock vests in full on the earlier of August 5, 2026, or Anterix Inc.'s next annual stockholder meeting.
- A total of 9,654 shares are directly beneficially owned by Mr. Heard following the transaction.
- An additional 1,716,738 shares are indirectly beneficially owned through Heard Capital LLC, for which Mr. Heard is the ultimate beneficial owner.
Sentiment
Score: 7
Explanation: The filing indicates a routine compensation event for a director, reinforcing alignment with shareholder interests. It's a positive signal of continued board engagement and investment, though not a major market-moving event.
Positives
- Grant of restricted stock to a director aligns his interests with shareholders, incentivizing long-term performance.
- The director's continued service and acceptance of equity compensation indicate ongoing commitment to the company.
- The director's significant indirect ownership (1,716,738 shares) through Heard Capital LLC demonstrates substantial investment in Anterix.
Risks
- Vesting of the restricted stock is subject to Anterix Inc.'s Insider Trading Policy, which could potentially delay the actual vesting date if it falls on a closed trading day.
Future Outlook
The restricted stock grant is set to vest on the earlier of August 5, 2026, or the company's next annual stockholder meeting, aligning the director's future compensation with long-term company performance.
Management Comments
- Each of Heard Capital LLC and the Reporting Person disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein.
Industry Context
This Form 4 filing reflects a routine compensation event for a non-employee director, common across publicly traded companies to incentivize board members and align their interests with shareholders. Such grants are standard practice in corporate governance within the broader financial and technology sectors.
Comparison to Industry Standards
- Granting restricted stock as compensation for non-employee directors is a common practice in the U.S. public company landscape, aligning director incentives with shareholder value.
- The $0 acquisition price is typical for compensation grants, reflecting the value of service rather than a cash purchase.
- The vesting schedule (one year or next annual meeting) is a standard approach to retain directors and ensure continued engagement, comparable to practices at companies like Verizon or AT&T in the telecommunications infrastructure space.
Stakeholder Impact
- Shareholders: The grant aligns the director's interests with shareholders, potentially fostering better long-term decision-making. The director's significant existing indirect stake also reinforces this alignment.
- Management: Standard compensation practices for non-employee directors are maintained.
Next Steps
- Vesting of the 7,767 restricted shares on the earlier of August 5, 2026, or Anterix Inc.'s next annual stockholder meeting.
Key Dates
| Date | Description |
|---|---|
| 08/05/2025 | Date of transaction for the restricted stock grant. |
| 08/07/2025 | Signature date of the Form 4 filing. |
| 08/05/2026 | Earliest vesting date for the restricted stock grant. |
Recommendation
holdThis Form 4 filing details a routine restricted stock grant to a director as part of their compensation. While it signifies continued alignment of the director's interests with the company's performance and demonstrates ongoing board engagement, it does not present new information that would fundamentally alter the investment thesis for Anterix Inc. It is a standard corporate governance event and does not warrant a change in investment recommendation based solely on this filing.
Keywords
Anterix, ATEX, Form 4, Insider Trading, Director Compensation, Restricted Stock, William Heard, Heard Capital LLC, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.